Biologics manufacturing is under increasing pressure to deliver therapies faster, more efficiently, and with uncompromising quality. To meet these demands, the industry is turning to outsourcing, advanced technologies, and stronger compliance frameworks.

This e-book, developed from Contract Manufacturing Europe 2025, explores strategies for streamlining processes, reducing costs, and enhancing quality in biologics production. Drawing on insights from biopharma executives, CDMOs, regulators, and technology leaders, it highlights practical approaches to fast-track manufacturing, tech transfer, sustainability, and regulatory alignment.

Read on to discover how the European biomanufacturing community is shaping the future of outsourcing.